Generated by GPT-5-mini| National Influenza Center (United Kingdom) | |
|---|---|
| Name | National Influenza Center (United Kingdom) |
| Type | Public health laboratory |
| Established | 1950s |
| Location | London, United Kingdom |
| Parent organisation | UK Health Security Agency |
National Influenza Center (United Kingdom) The National Influenza Center (United Kingdom) is the designated influenza reference laboratory for the United Kingdom, affiliated with the World Health Organization and operating within the UK Health Security Agency. It provides national influenza surveillance, laboratory confirmation, antigenic and genetic characterisation, and contributes to vaccine strain selection for the Seasonal influenza vaccine process, interacting with bodies such as the European Centre for Disease Prevention and Control, the Centers for Disease Control and Prevention, and the National Institutes of Health. The centre collaborates with clinical networks including NHS England, academic partners like Imperial College London and University of Oxford, and international consortia such as the Global Influenza Surveillance and Response System.
The centre traces its origins to post‑war influenza efforts linked to institutions such as the Public Health Laboratory Service and early WHO influenza laboratories, evolving through associations with the Royal Society and ties to London School of Hygiene & Tropical Medicine. During the 1957 Asian Flu and 1968 Hong Kong flu pandemics the laboratory network that became the centre worked alongside the Ministry of Health (United Kingdom) and the Medical Research Council to expand virological capacity. In later decades partnerships with Health Protection Agency and later reorganisations into Public Health England and UK Health Security Agency reflected shifts in national public health architecture, while scientific links to the Francis Crick Institute and Wellcome Trust supported modernisation.
The centre operates under the governance structures of the UK Health Security Agency and maintains reporting lines to the Department of Health and Social Care. Its governance includes scientific oversight from advisory groups that mirror panels like the Joint Committee on Vaccination and Immunisation and coordination with the European Influenza Surveillance Network and the WHO Global Influenza Programme. Operational units mirror divisions at institutions such as the National Institute for Biological Standards and Control and the Veterinary Laboratories Agency for zoonotic interfaces, and administrative links engage stakeholders including NHS England, academic centres such as King's College London, and regulatory bodies like the Medicines and Healthcare products Regulatory Agency.
The centre leads laboratory surveillance activities, receiving clinical specimens from sentinel schemes run by NHS England, primary care networks, and hospital trusts including Guy's and St Thomas' NHS Foundation Trust and University College London Hospitals NHS Foundation Trust. It implements viral isolation, real‑time RT‑PCR assays, next‑generation sequencing pipelines akin to work at Sanger Institute and antigenic characterisation comparable to methods used at the CDC Influenza Division. Data feed into international platforms such as the Global Initiative on Sharing All Influenza Data and inform outputs used by the European Centre for Disease Prevention and Control and WHO. Laboratory collaborations extend to veterinary and zoonosis partners including Animal and Plant Health Agency and academic centres like University of Cambridge and Scottish Centre for Infection and Environmental Health.
Research programmes at the centre intersect with vaccine development efforts involving the Medicines and Healthcare products Regulatory Agency, vaccine manufacturers like GlaxoSmithKline and Sanofi Pasteur, and translational research hubs including Imperial College London and University of Oxford. Studies encompass antigenic drift and shift analysis, haemagglutinin and neuraminidase characterisation, and evaluation of vaccine effectiveness paralleling work at the International Vaccine Institute and the European Medicines Agency. Collaborative projects with the National Institute for Health and Care Research, the Wellcome Trust and biotech partners such as AstraZeneca support trials, adjuvant research and candidate strain selection for the World Health Organization recommendations.
The centre provides diagnostic support for clinical services across NHS trusts and informs policy advice to the Department of Health and Social Care and advisory committees like the Joint Committee on Vaccination and Immunisation. It collaborates internationally with the World Health Organization, Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, and national influenza centres including those in United States, France, Germany, China, Japan and Australia. Partnerships with research universities such as University of Edinburgh, University of Glasgow, and Queen Mary University of London underpin modelling and burden studies akin to work by groups at Imperial College London and London School of Economics. The centre also engages with industry partners including Gilead Sciences and Moderna on antiviral and vaccine research.
The centre played central roles during the 2009 H1N1 pandemic coordinating strain characterisation alongside WHO reference laboratories, supporting clinical responses in NHS hospitals and informing vaccine procurement. During seasonal peaks and severe seasons such as the 2017–2018 influenza season the centre provided surveillance data that influenced national immunisation campaigns coordinated with NHS England and procurement activity involving manufacturers like GlaxoSmithKline and Sanofi. It has supported responses to zoonotic spillovers linked to avian influenza events connected to outbreaks investigated with Animal and Plant Health Agency and international notifications to the World Organisation for Animal Health.
Category:Public health in the United Kingdom Category:Virology